COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 171 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $223,517 | -17.5% | 10,401 | -7.9% | 0.01% | -28.6% |
| Q1 2023 | $270,991 | +8.7% | 11,296 | +5.2% | 0.01% | +16.7% |
| Q4 2022 | $249,191 | +5.6% | 10,741 | -27.1% | 0.01% | +20.0% |
| Q3 2022 | $236,000 | -70.4% | 14,732 | -56.4% | 0.01% | -28.6% |
| Q2 2021 | $798,000 | +474.1% | 33,751 | +387.3% | 0.01% | +250.0% |
| Q4 2020 | $139,000 | -97.7% | 6,926 | -98.2% | 0.00% | -97.5% |
| Q1 2019 | $5,982,000 | -3.8% | 395,080 | -6.4% | 0.08% | +2.6% |
| Q3 2018 | $6,220,000 | -38.6% | 421,993 | -0.6% | 0.08% | -34.7% |
| Q2 2018 | $10,126,000 | – | 424,590 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
| Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
| Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
| Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
| Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
| EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
| Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
| AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
| SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |